Physician profile
John Stanley Morgan
NPI 1134120876
$610.28
in general payments reported to CMS, 2019-2025
14 companies · $28.48 in 2025
The $28.48 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.93 · 2020: $130 · 2021: $112 · 2022: $205 · 2023: $48.07 · 2025: $28.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $76.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $76.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $150.47 | 2020-2022 | |
| Alcon Vision LLC | $85.52 | 2020-2022 | |
| Aerie Pharmaceuticals, INC. | $79.90 | 2019-2021 | |
| Apellis Pharmaceuticals, INC. | $48.07 | 2023 | |
| Pfizer INC. | $45.25 | 2020-2022 | |
| Oyster Point Pharma, INC. | $40.97 | 2022 | |
| Ocular Therapeutix, INC. | $39.76 | 2022 | |
| Biotissue Holdings INC. | $23.59 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $19.40 | 2019 | |
| Eyepoint US, INC. | $18.97 | 2019 | |
| Boston Scientific Corporation | $17.17 | 2025 | General - Pain Management |
| Sun Pharmaceutical Industries INC. | $15.82 | 2020 | |
| Novartis Pharmaceuticals Corporation | $14.08 | 2019 | |
| Meditrina | $11.31 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.